Literature DB >> 19682861

Association study of the gamma-aminobutyric acid type a receptor gamma2 subunit gene with schizophrenia.

Clement C Zai1, Arun K Tiwari, Nicole King, Vincenzo De Luca, Daniel J Mueller, Sajid Shaikh, Greg W H Wong, Herbert Y Meltzer, Jeffrey A Lieberman, James L Kennedy.   

Abstract

Schizophrenia (SCZ) is a severe neuropsychiatric disorder with a strong genetic basis. We analyzed eight GABRG2 and one DRD5 tag single-nucleotide polymorphisms for association with SCZ in 109 small nuclear families and 229 independent SCZ case-control pairs. The marker rs183294 in the 5' region of GABRG2 was found to be associated with SCZ in both samples with the C allele over-represented in SCZ cases and over-transmitted in SCZ families (combined z=9.18; p<1 x 10(-3)). Taken together, the results of the present study suggest that GABRG2 may be involved in SCZ susceptibility, but further studies are required.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19682861     DOI: 10.1016/j.schres.2009.07.010

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  3 in total

1.  Reduced binding potential of GABA-A/benzodiazepine receptors in individuals at ultra-high risk for psychosis: an [18F]-fluoroflumazenil positron emission tomography study.

Authors:  Jee In Kang; Hae-Jeong Park; Se Joo Kim; Kyung Ran Kim; Su Young Lee; Eun Lee; Suk Kyoon An; Jun Soo Kwon; Jong Doo Lee
Journal:  Schizophr Bull       Date:  2013-04-15       Impact factor: 9.306

2.  Sex differences in GABAergic gene expression occur in the anterior cingulate cortex in schizophrenia.

Authors:  Greg C Bristow; John A Bostrom; Vahram Haroutunian; Monsheel S Sodhi
Journal:  Schizophr Res       Date:  2015-02-07       Impact factor: 4.939

Review 3.  The role of the GABA system in amphetamine-type stimulant use disorders.

Authors:  Dongliang Jiao; Yao Liu; Xiaohong Li; Jinggen Liu; Min Zhao
Journal:  Front Cell Neurosci       Date:  2015-05-05       Impact factor: 5.505

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.